Laura Lovett
The company was spun out of Vituity and Inflect Health's innovation hub.
The tool can help users find locations for 25 different lab testing services, including blood tests, drug tests and HIV tests.
Also 23andMe names Dr. Joseph R. Aaron as its next chief scientific officer.
The stock took a tumble in October following the letter.
MobiHealthNews sits down with Andrew Le to talk about Buoy Health and the evolution of digital health during the pandemic.
Also: RenalSense scores $14 million for its renal diagnostic, and InsurMedix rakes in $15 million for fertility insurance.
This news comes just weeks after Philips announced its plans to acquire Cardiologs.
This comes roughly two years after Ro inked a deal with Plenity creator Gelesis.
The new skill will let patients verbally communicate with caregivers through Amazon Echo.
The company, founded in 2020, works with health plans.